Skip to content

Delcath Systems DCTH Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Boston Scientific logo
Boston ScientificBSX
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
Arcus Biosciences logo
Arcus BiosciencesRCUS
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO

Other financials

Income statement

See full
Revenue$25.0M+26.3%
Gross profit$21.3M+25.5%
Operating income-$1.6M-355%
Net income-$1.1M-200%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$41.3M+223%
Total debt$907.0K-10.7%
Total equity$112.7M+40.5%
Total assets$124.8M+43.0%

Cash flow

See full
Operating cash flow$857.0K-61.1%
CapEx$570.0K+307%
Free cash flow$287.0K-86.1%

Valuation

See full
Market cap$425.31M-11.8%
Enterprise value$384.91M-18.2%
P/E120.6×
P/S4.7×-4.3×

Profitability

See full
Gross margin86%+1.1pp
Operating margin-118.1%-56.8pp
Net margin1.5%+0.8pp
FCF margin21.2%+15.2pp

Returns & leverage

See full
Return on equity1.9%+1.0pp
Debt / equity0.0×
Current ratio11.2×-4.7×

Where this comes from

Reported directly by Delcath Systems in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Delcath Systems’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Delcath Systems's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Delcath Systems's common stock, shares authorized (in shares)?
Delcath Systems (DCTH) reported common stock, shares authorized (in shares) of $80M in Q1 2026.
How has Delcath Systems's common stock, shares authorized (in shares) changed year-over-year?
Delcath Systems's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $80M to $80M.
What is the long-term trend for Delcath Systems's common stock, shares authorized (in shares)?
Over 4 years (2021 to 2025), Delcath Systems's common stock, shares authorized (in shares) has grown at a 18.9% compound annual growth rate (CAGR), from $40M to $80M.